These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8142661)

  • 61. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery.
    Tamir L; Fradin Z; Fridlander M; Ashkenazi U; Zeidman A; Cohen AM; Hendel D; Mittelman M
    Haematologia (Budap); 2000; 30(3):193-201. PubMed ID: 11128112
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Transplant Proc; 1994 Jun; 26(3):1827-8. PubMed ID: 8030158
    [No Abstract]   [Full Text] [Related]  

  • 64. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Recovery of vascular niche in bone marrow by donor derived endothelial progenitor cells after allogeneic bone marrow transplantation in mice].
    Zhang Y; Song GL; Pan B; Hua J; Xu KL; Zeng LY
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):623-7. PubMed ID: 23134854
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.
    Blazar BR; Aukerman SL; Vallera DA
    Blood; 1992 Mar; 79(6):1636-42. PubMed ID: 1547353
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impaired erythropoietin response to anemia after bone marrow transplantation.
    Miller CB; Jones RJ; Zahurak ML; Piantadosi S; Burns WH; Santos GW; Spivak JL
    Blood; 1992 Nov; 80(10):2677-82. PubMed ID: 1421381
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
    Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Erythropoietin after bone marrow transplantation.
    Miller CB; Mills S
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):975-92. PubMed ID: 7852219
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery.
    Tiberghien P; Longo DL; Wine JW; Alvord WG; Reynolds CW
    Blood; 1990 Oct; 76(7):1419-30. PubMed ID: 2207317
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
    Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
    Transplantation; 2000 May; 69(10):2043-8. PubMed ID: 10852594
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
    Pavletic ZS; Bishop MR; Tarantolo SR; Martin-Algarra S; Bierman PJ; Vose JM; Reed EC; Gross TG; Kollath J; Nasrati K; Jackson JD; Armitage JO; Kessinger A
    J Clin Oncol; 1997 Apr; 15(4):1608-16. PubMed ID: 9193360
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Successful treatment using iron depletion phlebotomy combined with recombinant erythropoietin after allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by secondary hemochromatosis].
    Shinjo K; Takeshita A; Naito K; Ohnishi K; Hirabayashi N; Ohno R
    Rinsho Ketsueki; 2001 Jul; 42(7):571-4. PubMed ID: 11524849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.
    Beguin Y; Clemons GK; Oris R; Fillet G
    Blood; 1991 Feb; 77(4):868-73. PubMed ID: 1847085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patients.
    Danova M; Ferrari S
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):21-5. PubMed ID: 12082650
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of partially mismatched related donors extends access to allogeneic marrow transplant.
    Henslee-Downey PJ; Abhyankar SH; Parrish RS; Pati AR; Godder KT; Neglia WJ; Goon-Johnson KS; Geier SS; Lee CG; Gee AP
    Blood; 1997 May; 89(10):3864-72. PubMed ID: 9160695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.